ATE121719T1 - Calciumcitrat/malat-gemisch. - Google Patents
Calciumcitrat/malat-gemisch.Info
- Publication number
- ATE121719T1 ATE121719T1 AT91910588T AT91910588T ATE121719T1 AT E121719 T1 ATE121719 T1 AT E121719T1 AT 91910588 T AT91910588 T AT 91910588T AT 91910588 T AT91910588 T AT 91910588T AT E121719 T1 ATE121719 T1 AT E121719T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium
- solid
- neutral
- calcium citrate
- metastable
- Prior art date
Links
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 title abstract 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 title 1
- 239000001354 calcium citrate Substances 0.000 title 1
- 239000001362 calcium malate Substances 0.000 title 1
- 229940016114 calcium malate Drugs 0.000 title 1
- 235000011038 calcium malates Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 235000013337 tricalcium citrate Nutrition 0.000 title 1
- 239000007787 solid Substances 0.000 abstract 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000008043 acidic salts Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000292 calcium oxide Substances 0.000 abstract 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 229940049920 malate Drugs 0.000 abstract 1
- 235000011090 malic acid Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Amplifiers (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53731390A | 1990-06-14 | 1990-06-14 | |
| US60805590A | 1990-10-31 | 1990-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE121719T1 true ATE121719T1 (de) | 1995-05-15 |
Family
ID=27065458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91910588T ATE121719T1 (de) | 1990-06-14 | 1991-05-30 | Calciumcitrat/malat-gemisch. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0533724B1 (de) |
| JP (1) | JP3501800B2 (de) |
| AT (1) | ATE121719T1 (de) |
| AU (1) | AU660929B2 (de) |
| CA (1) | CA2085008C (de) |
| DE (1) | DE69109289T2 (de) |
| FI (1) | FI925669A0 (de) |
| IE (1) | IE66039B1 (de) |
| MX (1) | MX172988B (de) |
| MY (1) | MY110230A (de) |
| NZ (1) | NZ238527A (de) |
| PT (1) | PT97958B (de) |
| SA (1) | SA91120137B1 (de) |
| TR (1) | TR27617A (de) |
| WO (1) | WO1991019692A2 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993012672A1 (en) * | 1991-12-26 | 1993-07-08 | The Procter & Gamble Company | Storage stable calcium-supplemented beverage concentrates |
| US5389387A (en) * | 1991-12-26 | 1995-02-14 | The Procter & Gamble Company | Storage stable calcium-supplemented beverage concentrates |
| ATE140125T1 (de) * | 1992-10-21 | 1996-07-15 | Procter & Gamble | Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup |
| WO1994008472A1 (en) * | 1992-10-21 | 1994-04-28 | The Procter & Gamble Company | Concentrated bioavailable calcium source |
| EP0665719B1 (de) * | 1992-10-21 | 1997-01-15 | The Procter & Gamble Company | Eine konzentrierte lebensverfügbare kalziumsquelle enthaltender süssstof |
| CA2147836C (en) * | 1992-11-19 | 1999-10-05 | David Clinton Heckert | Method for enhancing bioavailability of beta-carotene |
| US5609897A (en) * | 1995-04-07 | 1997-03-11 | Abbott Laboratories | Powdered beverage concentrate or additive fortified with calcium and vitamin D |
| US5698222A (en) * | 1995-04-07 | 1997-12-16 | Abbott Laboratories | Calcium supplement |
| US5817351A (en) * | 1995-04-07 | 1998-10-06 | Abbott Laboratories | Calcium fortified low pH beverage |
| US5597595A (en) * | 1995-04-07 | 1997-01-28 | Abbott Laboratories | Low pH beverage fortified with calcium and vitamin D |
| GB2299992A (en) * | 1995-04-20 | 1996-10-23 | Willem Jacob Serfontein | Complexes of magnesium and calcium |
| US5681600A (en) * | 1995-12-18 | 1997-10-28 | Abbott Laboratories | Stabilization of liquid nutritional products and method of making |
| US6197835B1 (en) | 1996-05-13 | 2001-03-06 | Universidad De Sevilla | Device and method for creating spherical particles of uniform size |
| US5928691A (en) * | 1997-05-01 | 1999-07-27 | Nestec S.A. | Calcium complex and a process of making a food fortified with calcium |
| GB9920848D0 (en) * | 1999-09-04 | 1999-11-10 | Nutrahealth Ltd | Calcium fortified emulsified fat product and calcium salts and sources for the preparation thereof |
| CN101505730B (zh) * | 2006-08-17 | 2013-02-13 | 宝洁公司 | 包含柠檬酸苹果酸钙的组合物以及它们的制备方法 |
| JP5469464B2 (ja) * | 2006-12-14 | 2014-04-16 | ピュラック バイオケム ビー. ブイ. | クエン酸カルシウム微粒子および乳酸カルシウムを含んでいる粒子状組成物 |
| EP2247565B1 (de) * | 2008-02-08 | 2017-08-02 | PURAC Biochem BV | Metalllactat-pulver und herstellungsverfahren dafür |
| TR200908237A2 (tr) | 2009-11-02 | 2011-05-23 | Bi̇lgi̇ç Mahmut | Kalsiyum ve D vitamini içeren farmasötik bileşimler. |
| EP2561878B1 (de) | 2010-03-31 | 2018-03-07 | Toyo Suisan Kaisha, Ltd. | Calciumpräparat und verfahren zu seiner herstellung |
| KR101420315B1 (ko) | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
| WO2017031121A1 (en) | 2015-08-17 | 2017-02-23 | Liang Alfred Chi-Yeh | Liquid formulations containing picosulfate and magnesium citrate |
| TW201804996A (zh) | 2016-07-08 | 2018-02-16 | 輝凌責任有限公司 | 含有匹可硫酸鹽(picosulfate)之安定液體調配物 |
| LU500270B1 (en) * | 2021-06-10 | 2022-12-12 | Lucas Brendler | Carboxylic Acid Loaded Salt Carrier and the Method for Producing thereof |
| CN115710174B (zh) * | 2022-11-25 | 2026-03-10 | 南通励成生物工程有限公司 | 一种高密度柠檬酸苹果酸螯合物的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786510A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
| DE3875867T2 (de) * | 1987-08-28 | 1993-04-01 | Norwich Eaton Pharma | Kalziumzusaetze. |
-
1991
- 1991-05-30 AT AT91910588T patent/ATE121719T1/de not_active IP Right Cessation
- 1991-05-30 EP EP91910588A patent/EP0533724B1/de not_active Expired - Lifetime
- 1991-05-30 CA CA002085008A patent/CA2085008C/en not_active Expired - Lifetime
- 1991-05-30 DE DE69109289T patent/DE69109289T2/de not_active Expired - Lifetime
- 1991-05-30 FI FI925669A patent/FI925669A0/fi not_active Application Discontinuation
- 1991-05-30 JP JP51030591A patent/JP3501800B2/ja not_active Expired - Fee Related
- 1991-05-30 WO PCT/US1991/003779 patent/WO1991019692A2/en not_active Ceased
- 1991-05-30 AU AU79089/91A patent/AU660929B2/en not_active Expired
- 1991-06-12 PT PT97958A patent/PT97958B/pt not_active IP Right Cessation
- 1991-06-13 MY MYPI91001059A patent/MY110230A/en unknown
- 1991-06-13 MX MX026231A patent/MX172988B/es unknown
- 1991-06-13 IE IE201491A patent/IE66039B1/en not_active IP Right Cessation
- 1991-06-13 NZ NZ238527A patent/NZ238527A/en not_active IP Right Cessation
- 1991-06-13 TR TR00583/91A patent/TR27617A/xx unknown
- 1991-09-14 SA SA91120137A patent/SA91120137B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI925669L (fi) | 1992-12-14 |
| JPH05507692A (ja) | 1993-11-04 |
| MY110230A (en) | 1998-03-31 |
| SA91120137B1 (ar) | 2004-04-19 |
| WO1991019692A2 (en) | 1991-12-26 |
| FI925669A7 (fi) | 1992-12-14 |
| FI925669A0 (fi) | 1992-12-14 |
| PT97958A (pt) | 1992-03-31 |
| NZ238527A (en) | 1994-06-27 |
| TR27617A (tr) | 1995-06-13 |
| WO1991019692A3 (en) | 1992-03-19 |
| IE66039B1 (en) | 1995-12-13 |
| CA2085008C (en) | 1998-08-18 |
| CA2085008A1 (en) | 1991-12-15 |
| AU660929B2 (en) | 1995-07-13 |
| AU7908991A (en) | 1992-01-07 |
| EP0533724A1 (de) | 1993-03-31 |
| DE69109289D1 (de) | 1995-06-01 |
| JP3501800B2 (ja) | 2004-03-02 |
| EP0533724B1 (de) | 1995-04-26 |
| IE912014A1 (en) | 1991-12-18 |
| DE69109289T2 (de) | 1995-10-26 |
| MX172988B (es) | 1994-01-26 |
| PT97958B (pt) | 1998-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE121719T1 (de) | Calciumcitrat/malat-gemisch. | |
| EP0256645B1 (de) | Herstellung von reinen Aminosäurechelaten der pharmazeutischen Qualität | |
| EG19056A (en) | Pharmaceutical preparation containing ibuprofen and a methode of its production | |
| NO883308D0 (no) | Flytende kalsiumsupplement av lettloeselige blandinger av kalsiumforbindelse og sitronsyre. | |
| KR927003502A (ko) | 염기성 수산화 디카르복실산 칼슘 알루미늄과 그의 제조방법 및 용도 | |
| IE800781L (en) | Amino acids and analogues | |
| IL80852A0 (en) | Preparation of organic acids | |
| MY117606A (en) | Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids | |
| KR960703566A (ko) | 비등성 입자와 이의 제조공정(effervescent granulated material and method for its preparation) | |
| DE3063910D1 (en) | Production of fructose and useful by-products | |
| CA2187442A1 (en) | Solid Compositions Containing Amine Oxide-Maleic Acid Salts | |
| GB1520109A (en) | Process for production of solution of a basic aluminium salt and its use in water treatment | |
| EP0337464A3 (de) | Schweisshemmende Mittel und Verfahren zur Herstellung | |
| JPS6462302A (en) | Water-soluble chitosan salt and production thereof | |
| JPS5792520A (en) | Preparation of spherical calcium carbonate | |
| WO2001060183A3 (en) | Calcium-fortified, grape-based products and methods for making them | |
| US5430164A (en) | Enhanced solubilization of zinc and manganese methionine complex salts by addition of ferric ion | |
| AU591687B2 (en) | Rare-earth oxide precursors | |
| EP0342310A1 (de) | Zusammensetzung, die zweiwertiges Manganion enthält und Verfahren zu deren Herstellung | |
| JPS55108814A (en) | Preparation of stable, easily soluble, amorphous magnesium citrate powder for medical use | |
| US3931147A (en) | Water-soluble derivatives of sodium mannoheptonate | |
| CA2252670A1 (en) | Low ph acidic compositions | |
| JPS57156333A (en) | Preparation of goethite | |
| JPS51136700A (en) | Process for preparation of alkali salt of milk casein | |
| EP0368758A3 (de) | Zinncysteat, dessen Herstellung und dessen pharmazeutische und kosmetische Verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |